FIRST CLINICAL RESULTS OF ADCT‐402, A NOVEL PYRROLOBENZODIAZEPINE‐BASED ANTIBODY DRUG CONJUGATE (ADC), IN RELAPSED/REFRACTORY B‐CELL LINEAGE NHL. (June 2017) - Kahl, B.; Hamadani, M.; Caimi, P.F.; Reid, E.G.; Havenith, K.; He, S.; Feingold, J.M.; O'Connor, O.A.